Research progress in the quantitative structure-antitumor activity relationship studies of taxol derivatives

Chinese Pharmacological Bulletin

Volumn 24, Issue 3, 2008, Pages

  Li, Yan ^a   Wang, Yong Hua ^b   Fang, Hua ^a   Li, Lan Ting ^a   Zhang, Shu Wei ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b DALIAN OCEAN UNIVERSITY   (China)

Author keywords

Molecular modeling; QSAR; Taxoid; Taxol

Indexed keywords

10 DEACETYLBACCATIN III; 5 (20)DEOXYDOCETAXEL; BACCATIN III; DOCETAXEL; EPOTHILONE DERIVATIVE; PACLITAXEL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; DRUG RESEARCH; DRUG STRUCTURE; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW;

EID: 45349085566     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Hu X Y, Meng G, BaoY Y, et al. Relationships between induction of apoptosis by Taxol in Hela cells and apoptosis-related proteins[J]. Chin Pharmacol Bull, 2004, 20(9): 1063-7.
2. Zhen X L, Liu X L, Qian B C. Progress in tumor cell apoptosis induced by plant extracts[J]. Chin Pharmacol Bull, 2004, 20 (11): 1201-5.
3. Morita H, Gonda A, Wei L, et al. 3D QSAR analysis of taxoids from taxus cuspidata var. nana by comparative molecular field approach[J]. Bioor Med Chem Lett, 1997, 7(18): 2387-92.
4. Xu X, Xu Z G, Luo Y F, Li W H. Study on the quantitative structure-activity relationships of 10-oac-paclitaxel analogues[J]. Chin J Med Chem, 2001, 11(6): 317-21.
5. Manetti F, Forli S, Maccari L, et al. 3D QSAR studies of the interaction between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA). A combined pharmacophore generation and pseudoreceptor modeling approach applied to taxanes and epothilones[J]. Farmaco, 2003, 58(5): 357-61.
6. Williams H J, Moyna G, Scott A I. NMR and molecular modeling study of the conformations of taxol 2′-acetate in chloroform and aqueous dimethyl sulfoxide solutions[J]. J Med Chem, 1996, 39 (7): 1555-9.
7. Zhu Q Q, Guo Z R, Huang N, et al. Comparative molecular field analysis of a deries of paclitaxel analogues[J]. J Med Chem, 1997, 40(26): 4319-28.
8. Li B, Shi B X, Yuan Y J, et al. Development and application of 3D-quantitative structure-activity relationship model of paclitaxel analogues[J]. J Tianjin Univ, 2000, 33(1): 51-5.
9. Shi B X, Liang S L, Yuan Y J, et al. Studies on the quantitative structure-activity relationships of paclitaxel analogues[J]. Chem J Chin Univ, 2000, 21(3): 401-6.
10. Liu A L, Chi H L. Study on QSAR of taxol and its derivatives based on stepwise multivariate linear regression analysis[J]. J Chin Pharm Sci, 1997, 6(1): 18-21.
11. Islam M N, Song Y Q, Iskander M N. Investigation of structural requirements of anticancer activity at the paclitaxel/tubulin binding site using CoMFA and CoMSIA[J]. J Mol Graph Model, 2003, 21 (4): 263-72.
12. Milanesio M, Ugliengo P, Viterbo D. Ab initio conformational study of the phenylisoserine side chain of paclitaxel[J]. J Med Chem, 1999, 42(2): 291-9.
13. Roh E J, Kim D, Choi J Y, et al. Synthesis, biological activity and receptor-based 3-D QSAR study of 3′-N-substituted-3′-N- debenzoylpaclitaxel analogues[J]. Bioorg Med Chem, 2002, 10 (10): 3135-43.
14. Huang G Y, Guo J Y, Liang X T. Studies on structure modification and structure-activity relationship of new taxoids derived from SINENXAN A[J]. Acta Pharm Sin, 1998, 33(8): 576-86.
15. Liu R W, Yi D L, Wang D H, et al. Synthesis and structure activity relationships of novel 14β side chain taxol derivatives[J]. Acta Pharm Sin, 1998, 33(12): 910-8.
16. Braga S F, Galvão D S. A semiempirical study on the electronic structure of 10-deacetylbaccatin-III[J]. J Mol Graph Model, 2002, 21(1): 57-70.
17. Querelle O, Dubois J, Thoret S, et al. Synthesis of C2-C3′N-linked macrocyclic taxoids. Novel docetaxel analogues with high tubulin activity[J]. J Med Chem, 2004, 47(24): 5937-44.
18. Xu X, Xu Z G, Luo Y F. Neural network pattern recognition study on the quantitative structure-activity relationships of taxol analogue anti-tumor drugs[J]. J South China Normal Univ (Nat Sci), 2005, 4(4): 74-80.
19. Mohanraj S, Doble M. 3-D QSAR studies of microtubule stabilizing antimitotic agents towards six cancer cell lines[J]. QSAR Comb Sci, 2006, 25(10): 952-60.
20. Boge T C, Hepperle M, Vander Velde D G, et al. The Oxetane conformational lock of paclitaxel: structural analysis of D-secopaclitaxel[J]. Bioorg Med Chem Lett, 1999, 9(20): 3041-6.
21. Wang M M, Cornell B, Nettles J, et al. The oxetane ring in taxol [J]. J Org Chem, 2000, 65(4): 1059-68.
22. Wang M M, Xia X Y, Kim Y, et al. A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone[J]. Org Lett, 1999, 1(1): 43-6.
23. Samaranayake G, Magri N F, Jitraugsri C, et al. Reaction of taxol with electrophilic reagents and preparationof the rearranged taxol derivative with tubulin assemble activity[J]. J Org Chem, 1991, 56(17): 5114-9.
24. Marder-Karsenti R, Dubois J, Bricard L, et al. Synthesis and biological evaluation of d-ring-modified taxanes: 5 (20)-azadocetaxel analogs[J]. J Org Chem, 1997, 62(19): 6631-7.
25. Gunatilaka A A L, Ramdayal F D, Sarragiotto M H, et al. Synthesis and biological evaluation of novel paclitaxel (Taxol) d-ring modified analogues[J]. J Org Chem, 1999, 64(8): 2694-703.
26. Dubois J, Thoret S, Gue'ritte F, et al. Synthesis of 5 (20) deoxydocetaxel, a new active docetaxel analogue[J]. Tetrahedron Lett, 2000, 41(18): 3331-4.
27. Barboni L, Dalla A, Dutta D, et al. Novel D-seco paclitaxel analogues: synthesis, biological evaluation, and model testing[J]. J Org Chem, 2001, 66(10): 3321-9.
28. Ferjancic Z, Matovic R, Cekovic Z, et al. Synthesis, biological e-valuation, and modeling of a C, D-seco-taxoid[J]. Tetrahedron Lett, 2005, 46(30): 5049-52.
29. Kingston D G I. The shape of things to come: structural and synthetic studies of taxol and related compounds[J]. Phytochemistry, 2007, 68(14): 1844-54.
30. Johnson S A, Alearaz A A, Snyder J P. T-taxol and the electron crystallographic density in β-tubulin[J]. Org Lett, 2005, 7(25): 5549-52.
31. Barboni L, Giarlo G, Ricciutelli M, et al. Synthesis, modeling, and anti-tubulin activity of a D-seco paclitaxel analogue[J]. Org Lett, 2004, 6(4): 461-4.
32. Snyder J P, Nettles J H, Cornett B, et al. The binding conformation of taxol in β-tubulin: a model based on electron crystallographic density[J]. Proc Natl Acad Sci USA, 2001, 98(9): 5312 -6.
33. Kingston D G I, Bane S, Snyder J P. The taxol pharmacophore and the T-taxol bridging principle[J]. Cell Cycle, 2005, 4(2): 279-89.
34. Ganesh T, Norris A, Sharma S, et al. Design, synthesis, and bioactivity of simplified paclitaxel analogs based on the T-taxol bioactive conformation[J]. Bioorg Med Chem, 2006, 14(10): 3447 -54.
35. Ganesh T, Yang C, Norris A, et al. Evaluation of the tubulin-bound paclitaxel conformation: synthesis, biology and SAR studies of C-4 to C-3′ birdged paclitaxel analogs[J]. J Med Chem, 2007, 50(4): 713-25.
36. Tang S, Yang C, Brodie P, et al. Bridging converts a noncytotoxic nor-paclitaxel derivative to a cytotoxic analogue by constraining it to the T-taxol conformation[J]. Org Lett, 2006, 8(18): 3983-6.
37. Nikolakakis A, Wu J H, Batist G, et al. Design and syntheses of putative bioactive taxanes[J]. Bioorg Med Chem, 2002, 10(7): 2387-95.
38. Braga S F, Galvao D S. A structure-activity study of taxol, taxotere, and derivatives using the electronic indices methodology (EIM)[J]. J Chem Inf Comput Sci, 2003, 43(2): 699-706.